List of Excipients in API alogliptin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing alogliptin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | ALOGLIPTIN | alogliptin | 45802-087 | ALCOHOL | 2026-07-27 |
| Padagis Israel Pharmaceuticals Ltd | ALOGLIPTIN | alogliptin | 45802-087 | BUTYL ALCOHOL | 2026-07-27 |
| Padagis Israel Pharmaceuticals Ltd | ALOGLIPTIN | alogliptin | 45802-087 | CELLULOSE, MICROCRYSTALLINE | 2026-07-27 |
| Padagis Israel Pharmaceuticals Ltd | ALOGLIPTIN | alogliptin | 45802-087 | CROSCARMELLOSE SODIUM | 2026-07-27 |
| Padagis Israel Pharmaceuticals Ltd | ALOGLIPTIN | alogliptin | 45802-087 | FERRIC OXIDE RED | 2026-07-27 |
| Padagis Israel Pharmaceuticals Ltd | ALOGLIPTIN | alogliptin | 45802-087 | FERROSOFERRIC OXIDE | 2026-07-27 |
| Padagis Israel Pharmaceuticals Ltd | ALOGLIPTIN | alogliptin | 45802-087 | HYDROXYPROPYL CELLULOSE | 2026-07-27 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for alogliptin
Excipient focus: ALCOHOL
alogliptin drug variants containing ALCOHOL
alogliptin drug variants not containing ALCOHOL
Excipient focus: BUTYL ALCOHOL
alogliptin drug variants containing BUTYL ALCOHOL
alogliptin drug variants not containing BUTYL ALCOHOL
Excipient focus: CARNAUBA WAX
alogliptin drug variants containing CARNAUBA WAX
alogliptin drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
alogliptin drug variants containing CELLULOSE, MICROCRYSTALLINE
alogliptin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
alogliptin drug variants containing CROSCARMELLOSE SODIUM
alogliptin drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
alogliptin drug variants containing CROSPOVIDONE
alogliptin drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE RED
alogliptin drug variants containing FERRIC OXIDE RED
alogliptin drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
alogliptin drug variants containing FERRIC OXIDE YELLOW
alogliptin drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
alogliptin drug variants containing FERROSOFERRIC OXIDE
alogliptin drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
alogliptin drug variants containing HYDROXYPROPYL CELLULOSE
alogliptin drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE 2910
alogliptin drug variants containing HYPROMELLOSE 2910
alogliptin drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
alogliptin drug variants containing LACTOSE MONOHYDRATE
alogliptin drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
alogliptin drug variants containing MAGNESIUM STEARATE
alogliptin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
alogliptin drug variants containing MANNITOL
alogliptin drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
alogliptin drug variants containing POLYETHYLENE GLYCOL 8000
alogliptin drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYGLYCERYL-10 OLEATE
alogliptin drug variants containing POLYGLYCERYL-10 OLEATE
alogliptin drug variants not containing POLYGLYCERYL-10 OLEATE
Excipient focus: POVIDONE
alogliptin drug variants containing POVIDONE
alogliptin drug variants not containing POVIDONE
Excipient focus: SHELLAC
alogliptin drug variants containing SHELLAC
alogliptin drug variants not containing SHELLAC
Excipient focus: TALC
alogliptin drug variants containing TALC
alogliptin drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
alogliptin drug variants containing TITANIUM DIOXIDE
alogliptin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch